本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amylyx Pharmaceuticals

6.30
-0.2700-4.11%
盘后6.29-0.0089-0.14%16:48 EDT
成交量:137.76万
成交额:861.32万
市值:5.62亿
市盈率:-2.09
高:6.58
开:6.51
低:5.97
收:6.57
数据加载中...
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/10

重要事件披露

Form 8-K - Current report
2024/04/04

重要事件披露

Form 8-K - Current report
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/08

重要事件披露

Form 8-K - Current report
2024/02/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/19

SEC问询函

Form CORRESP - Correspondence
2023/12/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/14

重要事件披露

Form 8-K - Current report